XML 54 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Assumptions Used to Calculate Fair Value of Options
The following assumptions were used to calculate the fair value of the Company's options on the date of grant:
Year Ended December 31,
2021
Expected volatility56%
Expected life in years
6.2 – 6.3
Risk-free interest rate
0.79% – 1.15%
Dividend yield—%
Schedule of Stock Options Outstanding and Stock Option Activity
The following table presents a summary of the Company's stock options outstanding at and stock option activity during the year ended December 31, 2023 ("Price" reflects the weighted average exercise price per share):
(In thousands, except per share data)OptionsPriceWeighted
Average
Remaining
Contractual Term
Outstanding, January 1, 20237,510 $16.16 4.0 years
Granted— 
Exercised— 
Forfeited(120)13.23 
Expired(202)15.99 
Outstanding, December, 31, 20237,188 16.22 3.0 years
Exercisable6,549 16.70 2.7 years
Expected to Vest639 11.30 6.7 years
Summary of Unvested Options and Changes
A summary of the Company's unvested options and changes during the year ended December 31, 2023 is presented below:
(In thousands, except per share data)OptionsWeighted Average Grant Date Fair Value
Unvested, January 1, 20232,330 $5.51 
Granted— 
Vested (1)
(1,571)5.34 
Forfeited(120)5.16 
Unvested, December 31, 2023639 5.99 
(1)The total fair value of the options vested during the year ended December 31, 2023 was $8.4 million.
Summary of Restricted Stock Outstanding and Restricted Stock Activity
The following table presents a summary of the Company's RSUs outstanding and RSU activity as of and during the year ended December 31, 2023 (“Price” reflects the weighted average share price at the date of grant):
(In thousands, except per share data)AwardsPrice
Outstanding, January 1, 20236,249 $13.06 
Granted7,458 2.84 
Vested (restriction lapsed)(1,790)13.39 
Forfeited(306)11.69 
Outstanding, December 31, 202311,611 6.48 
Schedule of Stock by Class
The following table presents the Company's Class A Common Stock, Class B Common Stock and Special Warrants issued and outstanding:
(In thousands, except share and per share data)December 31,
2023
Class A Common Stock, par value $.001 per share, 1,000,000,000 shares authorized
124,299,288 
Class B Common Stock, par value $.001 per share, 1,000,000,000 shares authorized
21,347,363 
Special Warrants5,101,870 
  Total Class A Common Stock, Class B Common Stock and Special Warrants issued and outstanding150,748,521 
Schedule of Share-Based Payment Arrangement, Cost by Plan
The following table presents the Company's total share based compensation expense by award type for the years ended 2023, 2022, and 2021:

(In thousands)Year Ended December 31,
202320222021
RSUs$21,709 $21,048 $13,182 
Performance RSUs8,857 5,589 1,617 
Options5,059 8,820 8,744 
Total Share Based Compensation Expense$35,625 $35,457 $23,543 
Schedule of Loss Per Share
(In thousands, except per share data)Year Ended December 31,
 202320222021
NUMERATOR: 
Net loss attributable to the Company – common shares$(1,102,660)$(264,663)$(159,199)
DENOMINATOR(1):
 
Weighted average common shares outstanding - basic149,255 148,058 146,726 
  Stock options and restricted stock(2):
— — — 
Weighted average common shares outstanding - diluted149,255 148,058 146,726 
Net loss attributable to the Company per common share: 
Basic$(7.39)$(1.79)$(1.09)
Diluted$(7.39)$(1.79)$(1.09)

(1)All of the outstanding Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the years ended December 31, 2023, December 31, 2022 and December 31, 2021.
(2)Outstanding equity awards representing 13.6 million, 11.0 million and 10.5 million shares of Class A common stock of the Company for the years ended December 31, 2023, December 31, 2022, and December 31, 2021, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.